1. Home
  2. WHF vs VYGR Comparison

WHF vs VYGR Comparison

Compare WHF & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHF
  • VYGR
  • Stock Information
  • Founded
  • WHF 2011
  • VYGR 2013
  • Country
  • WHF United States
  • VYGR United States
  • Employees
  • WHF N/A
  • VYGR N/A
  • Industry
  • WHF Finance Companies
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHF Finance
  • VYGR Health Care
  • Exchange
  • WHF Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • WHF 219.2M
  • VYGR 165.5M
  • IPO Year
  • WHF 2012
  • VYGR 2015
  • Fundamental
  • Price
  • WHF $8.99
  • VYGR $2.74
  • Analyst Decision
  • WHF Sell
  • VYGR Strong Buy
  • Analyst Count
  • WHF 4
  • VYGR 8
  • Target Price
  • WHF $10.83
  • VYGR $14.33
  • AVG Volume (30 Days)
  • WHF 68.0K
  • VYGR 377.3K
  • Earning Date
  • WHF 05-12-2025
  • VYGR 05-06-2025
  • Dividend Yield
  • WHF 17.13%
  • VYGR N/A
  • EPS Growth
  • WHF N/A
  • VYGR N/A
  • EPS
  • WHF 0.39
  • VYGR N/A
  • Revenue
  • WHF $86,143,000.00
  • VYGR $66,958,000.00
  • Revenue This Year
  • WHF N/A
  • VYGR N/A
  • Revenue Next Year
  • WHF N/A
  • VYGR $45.34
  • P/E Ratio
  • WHF $22.85
  • VYGR N/A
  • Revenue Growth
  • WHF N/A
  • VYGR N/A
  • 52 Week Low
  • WHF $8.44
  • VYGR $2.65
  • 52 Week High
  • WHF $13.28
  • VYGR $9.55
  • Technical
  • Relative Strength Index (RSI)
  • WHF 40.51
  • VYGR 33.88
  • Support Level
  • WHF $8.80
  • VYGR $2.71
  • Resistance Level
  • WHF $9.30
  • VYGR $2.99
  • Average True Range (ATR)
  • WHF 0.21
  • VYGR 0.18
  • MACD
  • WHF -0.01
  • VYGR -0.05
  • Stochastic Oscillator
  • WHF 29.23
  • VYGR 10.86

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: